Trials / Completed
CompletedNCT02066077
The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy
The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy: A Randomized Clinical Trial And Its Standard Technology Promotion Research
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
1. To determine the influencing factors of modified electroconvulsive therapy (MECT); 2. To determine the influencing factors and reversibility of the cognitive impairment caused by MECT; 3. To determine the duration of efficacy of MECT and its affecting factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etomidate | |
| DRUG | Propofol | |
| DEVICE | Bilateral temporal MECT | |
| DEVICE | The right temporal MECT | |
| DEVICE | Bilateral frontal MECT |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2014-02-19
- Last updated
- 2018-04-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02066077. Inclusion in this directory is not an endorsement.